期刊
CELL
卷 161, 期 6, 页码 1252-1265出版社
CELL PRESS
DOI: 10.1016/j.cell.2015.05.023
关键词
-
资金
- NIH [U54 MH084681-01, 1 U54 HG005033-01, U54 MH084512-01, 1 U54 HG005032-01, 1 U54 HG005034-01, U54 MH084690-01, U54 MH084691-01, 1 U54 HG005031-01, U54 MH084659-01]
- Janssen
- Bristol-Myers Squibb
- AstraZeneca
Small-molecule probes can illuminate biological processes and aid in the assessment of emerging therapeutic targets by perturbing biological systems in a manner distinct from other experimental approaches. Despite the tremendous promise of chemical tools for investigating biology and disease, small-molecule probes were unavailable for most targets and pathways as recently as a decade ago. In 2005, the NIH launched the decade-long Molecular Libraries Program with the intent of innovating in and broadening access to small-molecule science. This Perspective describes how novel small-molecule probes identified through the program are enabling the exploration of biological pathways and therapeutic hypotheses not otherwise testable. These experiences illustrate how small-molecule probes can help bridge the chasm between biological research and the development of medicines but also highlight the need to innovate the science of therapeutic discovery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据